Product catalog
AGR-10
Size
10 240
compounds
Description
Library of compounds intended for use in agro/crop science
Download file
AGR-14
Size
14 160
compounds
Description
Designed for discovery of novel allosteric ligands
Download file
Size
4 800
compounds
Description
Carefully selected molecules via docking and visual evaluation
Download file
ABAC-32
Size
32 000
compounds
Description
Designed for the discovery of novel antibacterials
Download file
AVR-3200
Size
3 200
compounds
Description
Designed for discovery of new Nucleoside-like antivirals
Download file
Size
1 348
compounds
Description
Designed for discovery of new water channels modifiers
Download file
Size
7 171
compounds
Description
Designed for discovery of novel BACE inhibitors
Download file
BRD-15
Size
15 360
compounds
Description
Specially selected molecules to target bromodomains
Download file
CICL-10560
Size
10 560
compounds
Description
Designed for discovery of new Voltage-gated calcium channel blockers
Download file
CNS-47
Size
47 360
compounds
Description
Library of novel small molecules with high CNS MPO scores
Download file
COV-16800
Size
16 800
compounds
Description
Designed for the discovery of new SARS-CoV-2 and pan-Coronavirus antivirals
Download file
DNA-5760
Size
5 760
compounds
Description
Designed for identification of new actives against proteins essential for DNA stability
Download file
EPG-38080
Size
38 080
compounds
Description
Library of compounds focusing to hit on a number of epigenetic targets
Download file
ERL-8960
Size
8 960
compounds
Description
Designed to effectively target the receptor and block estrogen release
Download file
GML-2470
Size
2 470
compounds
Description
Specially synthesized set of compounds able to mimic glycosides and their interaction with proteins
Download file
GPR-53
Size
53 440
compounds
Description
Designed for discovery of new GPCR ligands
Download file
HBL-24
Size
24 000
compounds
Description
Designed for discovery of novel kinase ATP pocket binders
Download file
IDO-4800
Size
4 800
compounds
Description
IDO focused library designed by a combination of structure- and ligand-based methods
Download file
Size
52 927
compounds
Description
Designed for discovery of novel hits in Immuno-Oncology therapeutic area
Download file
ICL-36
Size
36 800
compounds
Description
Designed for discovery of new Ion Channels ligands
Download file
JAK-STAT-1280
Size
1 280
compounds
Description
Designed for efficient hit finding against a number of immune disorders, including RA
Download file
KNS-64960
Size
64 960
compounds
Description
Designed for discovery of novel protein kinase inhibitors
Download file
KYN-13
Size
13 120
compounds
Description
Designed for discovery of new regulators of methabolic disorders
Download file
LGR-6400
Size
6 400
compounds
Description
A sub-library of Enamine’s GPCR Library designed for discovery of novel lipid GPCR ligands
Download file
Size
1 388
compounds
Description
A set of LOXs inhibitors designed using docking and 2D similarity search
Download file
Size
2 468
compounds
Description
A set of compounds focused on targeting molecular chaperones
Download file
NML-320
Size
320 compounds
Descriptions
Small library of specially synthesized compounds
Download file
PDZ Domain Library
PDZ-1920
Size
1 920 compounds
Descriptions
Sublibrary of PPI-40
Download file
PML-8960
Size
8 960 compounds
Descriptions
Selected molecules able to mimic common protein motifs
Download file
Size
40 640 compounds
Descriptions
Designed for discovery of novel PPI inhibitors
Download file
RNA-28
Size
28 000 compounds
Descriptions
Designed to promote the discovery of new-generation medicine
Download file
CSHL-12160
Size
12 160 compounds
Descriptions
Designed for discovery of mild electrophilic inhibitors of the largest enzyme class
Download file
SICL-5440
Size
5 440 compounds
Descriptions
Designed for discovery of new Nav1.7 channel blockers
Download file
TBL-3200
Size
3 200
compounds
Description
Library of potential tubulins ligands
Download file
Support
We offer comprehensive support in developing your hit compounds. Naturally such programs are realised most efficiently when biological actives originate from our screening collection. However, even if the hit compounds are from the collections of other vendors lead identification and optimization projects can proceed most productively in our hands. Sometimes for this we only need to synthesize first examples of the given chemical series and validate synthesis route.
